Laryngeal involvement in mucous membrane pemphigoid predicts poor response to rituximab: IJDVL
Source- Wittenberg M, Worm M. Severe Refractory Paraneoplastic Mucous Membrane Pemphigoid Successfully Treated With Rituximab. Front Med (Lausanne). 2019;6:8.
Wittenberg M, Worm M. Severe Refractory Paraneoplastic Mucous Membrane Pemphigoid Successfully Treated With Rituximab. Front Med (Lausanne). 2019;6:8. Published 2019 Jan 29. doi:10.3389/fmed.2019.00008
Wittenberg M, Worm M. Severe Refractory Paraneoplastic Mucous Membrane Pemphigoid Successfully Treated With Rituximab. Front Med (Lausanne). 2019;6:8. Published 2019 Jan 29. doi:10.3389/fmed.2019.00008
Wittenberg M, Worm M. Severe Refractory Paraneoplastic Mucous Membrane Pemphigoid Successfully Treated With Rituximab. Front Med (Lausanne). 2019;6:8. Published 2019 Jan 29. doi:10.3389/fmed.2019.00008
Wittenberg M, Worm M. Severe Refractory Paraneoplastic Mucous Membrane Pemphigoid Successfully Treated With Rituximab. Front Med (Lausanne). 2019;6:8. Published 2019 Jan 29. doi:10.3389/fmed.2019.00008
Wittenberg M, Worm M. Severe Refractory Paraneoplastic Mucous Membrane Pemphigoid Successfully Treated With Rituximab. Front Med (Lausanne). 2019;6:8. Published 2019 Jan 29. doi:10.3389/fmed.2019.00008
Laryngeal mucous membrane pemphigoid a poor prognostic factor for rituximab treatment: IJDVL
Mucous membrane pemphigoid (MMP) is an autoimmune subepidermal bullous disease with a tendency to scar and may progress to blindness or airway obstruction. When it involves the eyes or larynx, Mucous membrane pemphigoid (MMP) tends to be refractory to conventional treatments and rituximab (RTX) has emerged as a potential therapeutic solution for MMP in the past few years. Recently a case series with a review describing the use of rituximab in MMP was described in the Clinical and Experimental Dermatology journal.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.